About Curia
Curia is a Healthcare company based in Burlington (United States) founded in 1999, and was acquired by Curia in June 2010. Aseptic filling of syringes, vials, and custom containers is developed. It operates on a Professional Services and Managed Services model. Curia offers products and services including Small Molecule Services, Generic APIs, Biologics Services, and Sterile Drug Product. Its focus areas include Pharmaceuticals and Contract Development and Manufacturing. Its legal entity is Curia Global, Inc.
Company details
Curia is established as a leading global contract development and manufacturing organization (CDMO) with over 30 years of experience. Services are provided across small molecules, generic APIs, and biologics, supporting drug discovery, development, and manufacturing. Operations are conducted through an integrated network of 23 facilities across North America, Europe, and India. Solutions are tailored to meet the needs of biopharma companies of all sizes, ensuring flexibility and scalability. Advanced technologies and scientific expertise are utilized to accelerate the delivery of therapies to patients.
- Headquarters Burlington, United States
- Stage Acquired
- SectorsHealthcare
- Website amriglobal.com
- Social LinkedIn X Facebook
- Acquired by Curia (Jun 2010)
- Legal Name Curia Global, Inc.
Products & Services of Curia
Curia offers a comprehensive portfolio of products and services, including Small Molecule Services, Generic APIs, Biologics Services, and Sterile Drug Product.
Services for small molecule drug discovery are provided.
Generic API manufacturing services are comprehensively offered.
Biologics discovery and manufacturing services are delivered.
Sterile drug product development services are provided.
Funding Insights of Curia
- Total Rounds 1
- Last Round Debt – Conventional — $1M
- First Round $1M
(Feb 2007)
All 1 funding rounds of Curia with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2007 | $1M | Debt – Conventional | – | – | – |
1 investors in total: 1 institutional.
Investors in Curia
Curia has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Curia.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Drug research, development, testing, and consulting services are provided. | 1991 | curiaglobal.com | Albany, United States |
Investor details for Curia
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Curia
3 dated milestones of Curia across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Curia is founded.
- Funding First funding round of $1.0M.
- Exit Acquired by Curia.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Curia (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Curia
Curia was founded in 1999 and raised its 1st funding round 8 years after it was founded.
Curia is headquartered in Burlington, United States. It is registered at Burlington, Vermont, United States.
Curia is established as a leading global contract development and manufacturing organization (CDMO) with over 30 years of experience. Services are provided across small molecules, generic APIs, and biologics, supporting drug discovery, development, and manufacturing. Operations are conducted through an integrated network of 23 facilities across North America, Europe, and India. Solutions are tailored to meet the needs of biopharma companies of all sizes, ensuring flexibility and scalability. Advanced technologies and scientific expertise are utilized to accelerate the delivery of therapies to patients.
Curia offers Small Molecule Services, Generic APIs, Biologics Services, and Sterile Drug Product.
Curia has 1 investor. Key investors include Curia.
Curia operates through Curia Global, Inc..
Yes. Curia was acquired by Curia in June 2010.